Search

Search Constraints

You searched for: Author/Creator Squadrilli, Anna

Search Results

1. ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non‐small cell lung cancer patients. Issue 11 (7th July 2015)

2. CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors. (October 2020)

3. Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab. (8th June 2018)

5. From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC. (May 2019)

6. KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC. (November 2019)

7. L718Q Mutation as New Mechanism of Acquired Resistance to AZD9291 inEGFR‐Mutated NSCLC. Issue 10 (October 2016)

8. PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors. Issue 1 (February 2022)